Also listed on Halozyme Therapeutics, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Dec 28, 2032 · High confidence
20-year base term ends Dec 28, 2032
Dec 28, 2012
Dec 28, 2032
Jul 16, 2024
This patent's term runs 569 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 2 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 28, 2012, when application 13/694,731, the earliest non-provisional in its chain, was filed (this one was filed May 21, 2021) | Dec 28, 2032 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +569 days, USPTO patent term adjustment record | Jul 20, 2034 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,865,400, US 11,066,656, US 12,077,791, US 9,447,401) | capped to Dec 28, 2032 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Dec 28, 2032 | High confidence |
This family
| US 9,447,401 | In force Mar 2034 | Mar 2034 |
| US 10,865,400 | In force Dec 2034 | Dec 2034 |
| US 11,041,149 | In force Dec 2032 | Dec 2032 |
| US 11,066,656 | In force Dec 2032 | Dec 2032 |
| US 12,091,692 | In force Nov 2031 | Nov 2031 |
| US 12,037,618 | this patent Dec 2032 | Dec 2032 |
| US 12,049,652 | In force Dec 2032 | Dec 2032 |
| US 12,054,758 | In force Dec 2032 | Dec 2032 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 24, 2021 Reel 56331, frame 355 | Shepard, H. Michael | Halozyme, Inc. | Assignment of Assignor's Interest |
| May 24, 2021 Reel 56331, frame 368 | Wei, Ge; Zhao, Qiping; Connor, Robert James | Halozyme Therapeutics, Inc. | Assignment of Assignor's Interest |
| May 24, 2021 Reel 56331, frame 431 | Halozyme Therapeutics, Inc. | Halozyme, Inc. | Assignment of Assignor's Interest |
| May 26, 2021 Reel 56396, frame 767 | Wei, Ge; Zhao, Qiping; Connor, Robert James | Halozyme Therapeutics, Inc. | Corrective Assignment to Correct the Docket Number Previously Recorded at Reel: 056331 Frame: 0368. Assignor(S) Hereby Confirms the Assignment . |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,865,400, US 11,066,656, US 12,077,791, US 9,447,401.